San Francisco-based Alto Pharmacy raised $200m in a late-stage funding round led by SoftBank Vision Fund, after reported talks of a merger with a blank-check firm backed by billionaire Alec Gores fell through late last year.
The company, which offers same-day delivery of prescription medicines, did not reveal its latest valuation, but was valued at more than $1 billion in early 2020 when it raised $250 million in a Series D funding round led by SoftBank, according to sources.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Several technology companies offering e-commerce services to customers have raised fresh capital or filed to go public in recent months as the COVID-19 pandemic accelerated the shift to online buying.
Alto Pharmacy, founded in 2015 as ScriptDash, was in talks of floating its shares in New York, which fell though late last year when the SPAC and Alto could not agree on valuation terms, according to a source familiar with the matter.
The company said on Thursday its revenue more than doubled in the past 12 months to over $700 million. It has also expanded its presence to 12 markets across the United States.
Source: Reuters
Can’t stop reading? Read more
Exclusive Interview: Torge Barkholtz on rethinking SME succession through operator-led investing
Exclusive Interview: Torge Barkholtz on rethinking SME succession through operator-led investing...
Rightsizing the right way
Rightsizing the right way Rightsizing an organization is never easy. But, it is a normal process...
Mozaik Investments acquires majority stake in Romania’s Genesis College, plans €30m expansion
Mozaik Investments acquires majority stake in Romania’s Genesis College, plans €30m expansion...